Quo­tient, buoyed by Covid-19 work, buys Ar­ci­no­va in ef­fort to build end-to-end CD­MO brand

Flush with cash from Covid-19 work, con­tract man­u­fac­tur­ers are hav­ing their own M&A mi­ni-boom. Now, a UK-based man­u­fac­tur­ing ser­vices firm is snag­ging an­oth­er com­pa­ny head­quar­ter on the Isles, look­ing to set up an end-to-end of­fer­ing for cus­tomers.

Not­ting­ham drug de­vel­op­er and man­u­fac­tur­ing ac­cel­er­a­tor Quo­tient an­nounced plans this week to buy Ar­ci­no­va, an­oth­er con­tract de­vel­op­er with over four decades in the in­dus­try.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.